As one of the top five centers for thoracic aortic, abdominal aortic and carotid stent grafting in the nation, Penn is among a handful of centers leading the movement towards endovascular surgery. Members of the Division of Vascular Surgery and Endovascular Therapy are involved in advanced FDA trials to investigate new ways to treat abdominal and thoracic aortic aneurysms.

The Hospital of the University of Pennsylvania's second endovascular surgery angiographic suite is dedicated to performing sophisticated endovascular interventions, including stent grafting for aortic aneurysms and angioplasty and stent grafting for peripheral arterial occlusive disease.

Intravascular ultrasound, angiography, 3D image reconstruction and image-based guidance are integrated and controlled by the operative team at tableside to streamline and optimize endovascular interventions.

Quality & Outcomes: Carotid Treatments for High–Risk Stroke Patients

Penn is a national leader in the treatment of carotid artery stenosis and stroke prevention and has performed more carotid interventions than any other medical center in the region.

Penn vascular surgeons currently treat more than 100 patients each year, with perioperative stroke and mortality rates below 1 percent.

For patients at high risk for a stroke from carotid plaque, treatments include traditional carotid endarterectomy as well as carotid stenting with distal protection. Patients with severe carotid stenosis are candidates for carotid endarterectomy while patients considered too high risk for surgery have the option of percutaneous angioplasty and stenting.

Stenosis as a result of atherosclerosis of the carotid system accounts for 25 percent of cerebrovascular accidents in the U.S. Penn is a national leader in the treatment of carotid stenosis and the development of new therapies for the condition.

Carotid Artery Stenting and Carotid Endarterectomy Procedures — 2012 Volumes

Procedure Volume Stroke and death rate
Carotid endarterectomies 81 1.35%
Carotid stents 36 <1%

A Longstanding History in Carotid Artery Treatments

Penn endovascular surgeons at took part in the first clinical trials of angioplasty and stenting for patients with severe carotid artery stenosis at high risk for carotid endarterectomy, leading to FDA approval of the first carotid stent with distal protection platform in the country.

A long-standing collaboration with Penn stroke neurologists has optimized care of patients with symptomatic and asymtomatic carotid disease.

The contributions of Penn Vascular were integral to Penn Medicine's designation as a comprehensive stroke care center.

Limb–Saving Endovascular Procedures for Peripheral Arterial Occlusive Disease

Penn vascular surgeons perform more than 500 procedures each year to treat peripheral arterial occlusive disease, including minimally invasive percutaneous interventions and limb-saving open conventional bypass surgery.

Approximately 30 percent of patients with peripheral arterial disease are referred to Penn by other specialists; these patients require limb salvage procedures after initially undergoing one or more interventions elsewhere.

With a combination of advanced technology and traditional operative approaches, Penn endovascular surgeons have been able to treat all types of conditions, ranging from claudication to critical limb ischemia. In addition, collaboration with plastic surgery has allowed surgeons to offer creative solutions for many of these complex patients who would otherwise lose their limbs.

Share This Page: